Search Results - "MUCHHAL, Umesh S"
-
1
Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
Published in Journal of allergy and clinical immunology (01-04-2012)“…Background Sequestration of IgE to prevent its binding to high-affinity IgE receptor FcϵRI on basophils and mast cells is an effective therapy for allergic…”
Get full text
Journal Article -
2
A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
Published in mAbs (01-11-2011)“…Bispecific antibodies based on full-length antibody structures are more optimal than fragment-based formats because they benefit from the favorable properties…”
Get full text
Journal Article -
3
Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function
Published in Blood (01-03-2012)“…HM1.24, an immunologic target for multiple myeloma (MM) cells, has not been effectively targeted with therapeutic monoclonal antibodies (mAbs). In this study,…”
Get full text
Journal Article -
4
Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine Release
Published in Clinical cancer research (01-07-2019)“…Despite advances in the treatment of multiple myeloma, new therapies are needed to induce more profound clinical responses. T-cell-redirected lysis triggered…”
Get full text
Journal Article -
5
Transcriptional Regulation of Plant Phosphate Transporters
Published in Proceedings of the National Academy of Sciences - PNAS (11-05-1999)“…Phosphorus is acquired by plant roots primarily via the high-affinity inorganic phosphate (Pi) transporters. The transcripts for Pi transporters are highly…”
Get full text
Journal Article -
6
A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats
Published in Methods (San Diego, Calif.) (01-02-2019)“…•A novel heterodimeric Fc platform for creating bispecific antibodies is presented.•Heterodimer yields over 95% are achieved with little change in Fc…”
Get full text
Journal Article -
7
Abstract 5549: Potency-reduced IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Interleukin-12 (IL12) is a proinflammatory cytokine produced by activated antigen-presenting cells that induces differentiation of Th1 cells and increased…”
Get full text
Journal Article -
8
Abstract 5000: Immunotherapy with anti-PSMA x anti-CD3 bispecific antibody stimulates potent killing of a human prostate cancer cell line and target-mediated T cell activation in monkeys: A potential therapy for prostate cancer
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…PSMA (Prostate-Specific Membrane Antigen) is a promising therapeutic target in prostate cancer. Exploiting the high and selective expression of PSMA in the…”
Get full text
Journal Article -
9
Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions
Published in Journal of molecular biology (12-03-2010)“…Fully human monoclonal antibodies (mAbs) derived from transgenic mice or human antibody libraries are the current state of the art for reducing the…”
Get full text
Journal Article -
10
Suppression of mast cell degranulation through a dual-targeting tandem IgE–IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb
Published in Immunology letters (30-03-2012)“…Highlights ► We generated an Fcε–Fcγ fusion protein (tandem Fc) to suppress mast cell activation. ► Enhanced binding to FcγRIIb via Fc engineering…”
Get full text
Journal Article -
11
Immune suppression in cynomolgus monkeys by XPro9523: An improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn
Published in mAbs (01-05-2013)“…The CTLA4-Ig fusion proteins abatacept and belatacept are clinically proven immunosuppressants used for rheumatoid arthritis and renal transplant,…”
Get full text
Journal Article -
12
Phosphate transporters from the higher plant Arabidopsis thaliana
Published in Proceedings of the National Academy of Sciences - PNAS (17-09-1996)“…Two cDNAs (AtPT1 and AtPT2) encoding plant phosphate transporters have been isolated from a library prepared with mRNA extracted from phosphate-starved…”
Get full text
Journal Article -
13
Tomato phosphate transporter genes are differentially regulated in plant tissues by phosphorus
Published in Plant physiology (Bethesda) (01-01-1998)“…Phosphorus is a major nutrient acquired by roots via high-affinity inorganic phosphate (Pi) transporters. In this paper, we describe the tissue-specific…”
Get full text
Journal Article -
14
Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants
Published in Science (American Association for the Advancement of Science) (26-09-2003)“…Tumor necrosis factor (TNF) is a key regulator of inflammatory responses and has been implicated in many pathological conditions. We used structure-based…”
Get full text
Journal Article -
15
Differential expression of TPS11, a phosphate starvation-induced gene in tomato
Published in Plant molecular biology (01-03-1997)“…Plants respond to phosphate (Pi) deficiency through adaptive mechanisms involving several morphological, biochemical and molecular changes. In this study, we…”
Get full text
Journal Article -
16
Abstract 1831: Affinity tuned XmAb®2+1 GPC3 x CD3 bispecific antibodies demonstrate selective activity in liver cancer models
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Bispecific T cell engagers simultaneously bind CD3 on T cells and tumor-associated antigens to promote T cell-mediated killing of tumor cells. These agents…”
Get full text
Journal Article -
17
Abstract 5654: Affinity tuned Xmab®2+1 anti-mesothelin x anti-CD3 bispecific antibody induces selective T cell-dependent cellular cytotoxicity of human ovarian cancer cells
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Mesothelin (MSLN) is a tumor-associated antigen highly expressed in ovarian tumors. Current treatment options for ovarian cancer have only modest efficacy and…”
Get full text
Journal Article -
18
Abstract 1743: IL12 heterodimeric Fc-fusions engineered for reduced potency exhibit strong anti-tumor activity and improved therapeutic index compared to native IL12 agents
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Interleukin-12 (IL12) is a proinflammatory cytokine produced by activated antigen-presenting cells that induces differentiation of Th1 cells and increased…”
Get full text
Journal Article -
19
Abstract 1880: PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…T cells in the tumor micro-environment require TCR/MHC engagement and co-stimulatory receptor engagement to achieve complete activation. Tumor cells lack…”
Get full text
Journal Article -
20
Abstract 5663: Affinity tuned XmAb®2+1 PSMA x CD3 bispecific antibodies demonstrate selective activity in prostate cancer models
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Bispecific antibodies enable therapeutic modalities inaccessible to traditional mAbs, such as T cell engagers that bind both CD3 on T cells and a target…”
Get full text
Journal Article